Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-To-Severe Psoriasis in the United States
Dermatology and Therapy - Germany
doi 10.1007/s13555-018-0251-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 13, 2018
Authors
Publisher
Springer Science and Business Media LLC